We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 26, 2022

Sacubitril/Valsartan vs Ramipril for Patients With Acute MI

European Journal of Heart Failure


Additional Info

European Journal of Heart Failure
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial
Eur. J. Heart Fail 2022 Aug 29;[EPub Ahead of Print], O Berwanger, M Pfeffer, B Claggett, KS Jering, AP Maggioni, PG Steg, R Mehran, EF Lewis, Y Zhou, P van der Meer, C De Pasquale, B Merkely, G Filippatos, JJV McMurray, CB Granger, SD Solomon, E Braunwald

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading